Home / Icatibant / United States
US ATC B06AC02 · updated 2 Nov 2026
Icatibant shortage in United States
Is there an Icatibant shortage in United States?
Yes. As of 2 Nov 2026, 2 Icatibant products are reported short in United States, the first since 7 May 2026. No return date has been given. Main reason: not stated.
Also short in France, Italy, Spain, Ireland, Austria, Norway, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86) discontinuation | Fresenius Kabi USA, LLC | 7 May 2026 | not given | Not stated |
| US | Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93) discontinuation | Fresenius Kabi USA, LLC | 7 May 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).